These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 35891167)

  • 21. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
    Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
    Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ad5-nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants.
    Kong W; Zhong Q; Chen M; Yu P; Xu R; Zhang L; Lai C; Deng M; Zhou Q; Xiong S; Liang Y; Wan L; Lin M; Wang M; Mai W; Chen L; Lei Y; Qin N; Zhu J; Ruan J; Huang Q; Kang A; Wang J; Li W; Ji T
    J Med Virol; 2023 Jan; 95(1):e28163. PubMed ID: 36127294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection.
    Kim J; Seo H; Kim HW; Kim D; Kwon HJ; Kim YK
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants.
    Jalali N; Brustad HK; Frigessi A; MacDonald EA; Meijerink H; Feruglio SL; Nygård KM; Rø G; Madslien EH; de Blasio BF
    Nat Commun; 2022 Sep; 13(1):5706. PubMed ID: 36175424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant.
    Wu J; Wei Y; Shen F; Zhu S; Lu Y; Tian X; Zhang P
    Front Cell Infect Microbiol; 2022; 12():943407. PubMed ID: 35873164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort.
    Ma E; Ai J; Zhang Y; Zheng J; Gao X; Xu J; Yin H; Fu Z; Xing H; Li L; Sun L; Huang H; Zhang Q; Xu L; Jin Y; Chen R; Lv G; Zhu Z; Zhang W; Wang Z
    Emerg Microbes Infect; 2022 Dec; 11(1):2636-2644. PubMed ID: 36227753
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants.
    Kim YC; Kim B; Son NH; Heo N; Nam Y; Shin A; Yang AJ; Kim MH; Kyong T; Kang E; Park YS; Kim H
    J Korean Med Sci; 2023 Jan; 38(1):e9. PubMed ID: 36593690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
    Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
    EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons.
    Montecalvo MA; Visintainer P; Drugge E; Kowalski K; Raffa R; McKenna D; Moronta C; Wormser GP
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543961
    [No Abstract]   [Full Text] [Related]  

  • 30. Household transmission of the SARS-CoV-2 Omicron variant in Denmark.
    Lyngse FP; Mortensen LH; Denwood MJ; Christiansen LE; Møller CH; Skov RL; Spiess K; Fomsgaard A; Lassaunière R; Rasmussen M; Stegger M; Nielsen C; Sieber RN; Cohen AS; Møller FT; Overvad M; Mølbak K; Krause TG; Kirkeby CT
    Nat Commun; 2022 Sep; 13(1):5573. PubMed ID: 36151099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection.
    Simayi A; Li C; Chen C; Wang Y; Dong C; Tian H; Kong X; Zhou L; Peng J; Zhang S; Zhu F; Hu J; Xu K; Jin H; Fan H; Bao C; Zhu L
    Front Immunol; 2023; 14():1083523. PubMed ID: 36761738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines.
    Zhang B; Huo J; Huang Y; Teo SY; Duan K; Li Y; Toh LK; Lam KP; Xu S
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type.
    Dingemans J; van der Veer BMJW; Gorgels KMF; Hackert V; den Heijer CDJ; Hoebe CJPA; Savelkoul PHM; van Alphen LB
    Front Microbiol; 2022; 13():1027271. PubMed ID: 36504818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan.
    Jamal Z; Haider M; Ikram A; Salman M; Rana MS; Rehman Z; Haider SA; Ammar M; Nisar N; Umair M
    Front Public Health; 2022; 10():987452. PubMed ID: 36249252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of morbidity and mortality of SARS-CoV-2 in nursing homes for the elderly in Frankfurt am Main, Germany, 2020-2022: What protective measures are still required?
    Heudorf U; Domann E; Förner M; Kunz S; Latasch L; Trost B; Steul K
    GMS Hyg Infect Control; 2023; 18():Doc05. PubMed ID: 36875328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Association Between mRNA Vaccination and Infection From the Omicron Strain of SARS-CoV-2: A Population-Level Analysis.
    Plaxco AP; Kmet JM; Nolan VG; Taylor MA; Smeltzer MP
    AJPM Focus; 2022 Sep; 1(1):100010. PubMed ID: 36942019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong.
    Zee ST; Kwok LF; Kee KM; Fung LH; Luk WP; Chan TL; Leung CP; Yu PW; Hung J; SzeTo KY; Chan WL; Tang SF; Lin WC; Ma SK; Lee KH; Lau CC; Yung WH
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antibody responses in vaccinated and unvaccinated individuals infected with Omicron BA.1 variant.
    Oh SJ; O SW; Choi YJ; Kim JM; Kim D; Kim IH; Park AK; Kim HM; Rhee JE; Jang YR; Yoo CK; Kim JY; Kim EJ
    J Clin Virol; 2022 Oct; 155():105253. PubMed ID: 35988369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.